Time to first cigarette after waking predicts cotinine levels

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3415-3420

  Muscat, Joshua E ^a   Stellman, Steven D ^b   Caraballo, Ralph S ^c   Richie Jr , John P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ADULT; ARTICLE; CIGARETTE SMOKING; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SMOKING; TIME FACTORS; TOBACCO USE DISORDER; WAKEFULNESS; YOUNG ADULT;

EID: 73349127440     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0737     Document Type: Article

References (41)

1. Richie JP, Jr., Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev 1997;6:783-90.
2. Adda J, Cornaglia F. Taxes, cigarette consumption, and smoking intensity. Am Econ Rev 2006;96:1013-28.
3. Matsukura S, Sakamoto N, Seino Y, Tamada T, Matsuyama H, Muranaka H. Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 1979;25:555-61.
4. Hill P, Haley NJ, Wynder EL. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis 1983;36:439-49.
5. Bridges RB, Combs JG, Humble JW, Turbek JA, Rehm SR, Haley NJ. Population characteristics and cigarette yield as determinants of smoke exposure. Pharmacol Biochem Behav 1990;37:17-28.
6. Law MR, Morris JK, Watt HC, Wald NJ. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer 1997;75:1690-3.
7. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 1998;280:135-9.
8. Blackford AL, Yang G, Hernandez-Avila M, et al. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev 2006; 15:1799-804.
9. Lubin JH, Caporaso N, Hatsukami DK, Joseph AM, Hecht SS. The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev 2007;16:1852-7.
10. O'Connor RJ, Giovino GA, Kozlowski LT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol 2006; 164:750-9.
11. Mucha L, Stephenson J, Morandi N, Dirani R. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 2006;3:279-91.
12. Wynder EL, Stellman SD. Comparative epidemiology of tobaccorelated cancers. Cancer Res 1977;37:4608-22.
13. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000;463:103-10.
14. Lubin J, Caparaso N. Cigarette smoking exposure and lung cancer: modeling total exposure levels. Cancer Epidemiol Biomarkers Prev 2006;15:517-23.
15. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008;83:531-41.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
17. Fagerström K. Time to first cigarette; the best single indicator of tobacco dependence? Monaldi Arch Chest Dis 2003;59:91-4.
18. Baker TB, Piper ME, McCarthy DE, et al. Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007;9: S555-70.
19. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994;34: 211-6.
20. Toll BA, Schepis TS, O'Malley SS, McKee SA, Krishnan-Sarin S. Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study. Drug Alcohol Depend 2007; 89:302-5.
21. Pillitteri JL, Kozlowski LT, Sweeney CT, Heatherton TF. Individual differences in the subjective effects of the first cigarette of the day: a selfreport method for studying tolerance. Exp Clin Psychopharmacol 1997;5:83-90.
22. Haberstick BC, Timberlake D, Ehringer MA, et al. Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 2007;102:655-65.
23. Figueiredo VC, Szklo M, Szklo AS, et al. Determinants of salivary cotinine level: a population-based study in Brazil. Rev Saude Publica 2007;41:954-62.
24. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989;84:791-9.
25. Fagerström K-O, Bates S. Compensation and effective smoking by different nicotine dependent smokers. Addict Behav 1981;6:331-6.
26. Grainge MJ, Shahab L, Hammond D, O'Connor RJ, McNeill A. First cigarette on waking and time of day as predictors of puffing beha?viour in UK adult smokers. Drug Alcohol Depend 2009;101: 191-5.
27. Scherer G. Smoking behaviour and compensation. A review of the literature. Psychopharmacology 1999;145:1-20.
28. Pauly JR. Gender differences in tobacco smoking dynamics and the neuropharmacological actions of nicotine. Front Biosci 2008; 13:505-16.
29. Shiffman S, Paton SM. Individual differences in smoking: gender and nicotine addiction. Nicotine Tob Res 1999;1:S153-7.
30. Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103:1069-81.
31. Alessio L, Berlin A, Dell'Orto A, Toffoletto F, Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health 1985;55: 99-106.
32. Carrieri M, Trevisan A, Bartolucci GB. Adjustment to concentrationdilution of spot urine samples: correlation between specific gravity and creatinine. Int Arch Occup Environ Health 2001;74:63-7.
33. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200.
34. Nermell B, Lindberg AL, Rahman M, et al. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 2008;106: 212-8.
35. Thompson SG, Barlow RD, Wald NJ, Van Vunakis H. How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta 1990;187:289-95.
36. Hatsukami DK, Joseph AM, Lesage M, et al. Developing the science base for reducing tobacco harm. Nicotine Tob Res 2007;9:S537-53.
37. Ashley DL, Burns D, Djordjevic M, et al; WHO Study Group on Tobacco Product Regulation. The scientific basis of tobacco product regulation. World Health Organ Tech Rep Ser 2008;1-277.
38. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;CD000146.
39. Hatsukami DK, Le CT, Zhang Y, et al. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev 2006;15:2355-8.
40. Robles GI, Singh-Franco D, Ghin HL. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Clin Ther 2008;30:800-12.
41. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009;169:236-48.